Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Carnino

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The treatment of progressive ovarian carcinoma with D-Trp-LHRH (Decapeptyl). Gruppo Oncologico Nord ovest (GONO)F Carnino, L Iskra, G Fuda, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group StudyM George, V Scotto, F Carnino, et al.
Gynecologic Oncology|April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerE Campora, M Bruzzone, S Chiara, et al.
Gynecologic Oncology|June 12, 2003
First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patientsA Romanini, L Tanganelli, F Carnino, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO)A Gadducci, I Brunetti, M Bruzzone, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1985
High dose cisplatin after failure of polychemotherapy containing cisplatin in ovarian cancer. Preliminary resultsM Bruzzone, P F Conte, S Chiara, et al.
Progress in Clinical and Biological Research|January 1, 1990
Target cells for GM-CSF and kinetics of responseM Aglietta, F Bussolino, W Piacibello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinomaP F Conte, M Bruzzone, F Carnino, et al.
American Journal of Clinical Oncology|February 1, 1994
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapyS Chiara, P Conte, P Franzone, et al.
Critical Reviews in Oncology/Hematology|February 13, 2001
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapyS Chiara, R Lionetto, M Vincenti, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The treatment of progressive ovarian carcinoma with D-Trp-LHRH (Decapeptyl). Gruppo Oncologico Nord ovest (GONO)F Carnino, L Iskra, G Fuda, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group StudyM George, V Scotto, F Carnino, et al.
Gynecologic Oncology|April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerE Campora, M Bruzzone, S Chiara, et al.
Gynecologic Oncology|June 12, 2003
First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patientsA Romanini, L Tanganelli, F Carnino, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO)A Gadducci, I Brunetti, M Bruzzone, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1985
High dose cisplatin after failure of polychemotherapy containing cisplatin in ovarian cancer. Preliminary resultsM Bruzzone, P F Conte, S Chiara, et al.
Progress in Clinical and Biological Research|January 1, 1990
Target cells for GM-CSF and kinetics of responseM Aglietta, F Bussolino, W Piacibello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinomaP F Conte, M Bruzzone, F Carnino, et al.
American Journal of Clinical Oncology|February 1, 1994
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapyS Chiara, P Conte, P Franzone, et al.
Critical Reviews in Oncology/Hematology|February 13, 2001
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapyS Chiara, R Lionetto, M Vincenti, et al.
Pageof 5